Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Autor: Njei B; Department of Medicine, Yale School of Medicine, New Haven, USA., Al-Ajlouni Y; Department of Medicine, New York Medical College, New York, USA., Lemos SY; Department of Diabetes and Endocrinology, Yaoundé General Hospital, Yaoundé, CMR., Ugwendum D; Department of Internal Medicine, Richmond University Medical Center Affiliated with Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, Staten Island, USA., Ameyaw P; Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, USA., Njei LP; Department of Biological Science, University of Maryland Baltimore County, Baltimore, USA., Boateng S; Department of Medicine, Bridgeport Hospital, Bridgeport, USA.

Publikováno v: Cureus [Cureus] 2024 Oct 13; Vol. 16 (10), pp. e71366. Date of Electronic Publication: 2024 Oct 13 (Print Publication: 2024).